Search Results 8271-8280 of 33109 for oral

  1. Holly L. Geyer, M.D. - Doctors and Medical Staff - Mayo Clinic

    Second Runner Up for Oral Presentation in Clinical ResearchMayo Clinic Arizona Academic Excellence Day, Department of Education Administration. 2007.

  2. Robert R. Cima, M.D. - Doctors and Medical Staff - Mayo Clinic

    Associate Board ExaminerOral Boards, American Board of Surgery. 2009 - 2015. Medical Directorinstitution. 2009 - 2012. Executive Committee MemberSurgical and ...

  3. Meet our medical editors - Mayo Clinic

    Ettinger, M.D., D.D.S. — Oral and Maxillofacial Surgeon, Surgical Oncologist; Robert P. Frantz, M.D. — Cardiologist, Internist; Allison E. Garda, M.D. ...

  4. A Study to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly - Mayo Clinic

    Currently receiving other treatments known to affect GH or IGF-1 concentration (including oral estrogens for e.g. contraception or replacement treatment in ...

  5. Intensity-Modulated Radiation Therapy and Paclitaxel with or without Pazopanib Hydrochloride in Treating Patients with Anaplastic Thyroid Cancer - Mayo Clinic

    Patients with any condition that may impair the ability to absorb oral medications/investigational product including: Prior surgical procedures affecting ...

  6. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

    Immunosuppressive or immunomodulating treatment, including chronic oral or IV steroids, must be discontinued at least 4 weeks prior to screening. History of ...

  7. Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission - Mayo Clinic

    Eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, has been shown to increase platelet counts in adults with chronic immune thrombocytopenia ...

  8. Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

    Able to take oral medication without crushing, dissolving or chewing tablets. Patients must have a life expectancy ≥ 6 months. Patients may have received ...

  9. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

  10. Ruxolitinib Cream in Participants With Hidradenitis Suppurativa Topical Ruxolitinib Evaluation in Hidradenitis Suppurativa - Mayo Clinic

    Note 2: Use of oral corticosteroids for nondermatological conditions (eg, asthma exacerbation, bronchitis) is allowed for no longer than 7 days if deemed ...